We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Cobra Biologics and The University of Manchester Announce Collaboration

Agreement brings together academic and industrial expertise for the scaled manufacture of therapeutic proteins.
News

AGM Trading Update

CTX stem cell therapy candidate currently in a UK Phase II clinical trial.
News

Regeneron, Icahn School of Medicine at Mount Sinai Collaborate

The agreement sets out with the goal of accelerating the discovery of fully human antibodies directed against therapeutic targets being researched by Mount Sinai investigators.
News

ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75 Million

Acquisition significantly advances ANI’s core strategy of re-commercializing previously approved products.
News

Viruses Join Fight Against Harmful Bacteria

Engineered viruses could combat human disease and improve food safety.
News

Drug Disarms Deadly C. difficile Bacteria Without Destroying Healthy Gut Flora

A drug that blocks the intestinal pathogen without killing resident, beneficial microbes may prove superior to antibiotics, currently the front-line treatment for the infection.
News

New Virus Identified In Blood Supply

Scientists have discovered a new virus that can be transmitted through the blood supply.
News

BioClinica Acquires Synowledge

Adds capabilities in pharmacovigilance and regulatory technology, data analysis and business process management.
News

Xenon Achieves Milestone in Genentech Collaboration

Collaboration to discover novel pain targets.
News

MediSieve Gets £350,000 Cash Injection

Dr George Frodsham secure seed funding to develop revolutionary magnetic malaria-filter.
Advertisement